OA20421A - Method for controlling harmful insects. - Google Patents
Method for controlling harmful insects. Download PDFInfo
- Publication number
- OA20421A OA20421A OA1202000422 OA20421A OA 20421 A OA20421 A OA 20421A OA 1202000422 OA1202000422 OA 1202000422 OA 20421 A OA20421 A OA 20421A
- Authority
- OA
- OAPI
- Prior art keywords
- particle
- particles
- composite
- titanium oxide
- métal
- Prior art date
Links
- 241000238631 Hexapoda Species 0.000 title claims abstract description 66
- 239000002245 particle Substances 0.000 claims abstract description 272
- 239000011246 composite particle Substances 0.000 claims abstract description 160
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 102
- OGIDPMRJRNCKJF-UHFFFAOYSA-N TiO Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 95
- 229910001929 titanium oxide Inorganic materials 0.000 claims abstract description 95
- QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 66
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 66
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 65
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 64
- 235000013601 eggs Nutrition 0.000 claims abstract description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 59
- 241000255925 Diptera Species 0.000 claims description 39
- 239000004745 nonwoven fabric Substances 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 16
- 208000003558 Zoonosis Diseases 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 11
- 206010048282 Zoonosis Diseases 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000002923 metal particle Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 92
- 239000011230 binding agent Substances 0.000 description 39
- BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 37
- 229910052709 silver Inorganic materials 0.000 description 37
- 239000004332 silver Substances 0.000 description 37
- 229920005989 resin Polymers 0.000 description 35
- 239000011347 resin Substances 0.000 description 35
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 30
- 238000004519 manufacturing process Methods 0.000 description 19
- 239000000047 product Substances 0.000 description 18
- 239000011259 mixed solution Substances 0.000 description 17
- 239000011324 bead Substances 0.000 description 16
- 230000017448 oviposition Effects 0.000 description 16
- 230000032696 parturition Effects 0.000 description 16
- 241000256113 Culicidae Species 0.000 description 15
- 239000002270 dispersing agent Substances 0.000 description 15
- 239000002994 raw material Substances 0.000 description 15
- 238000002296 dynamic light scattering Methods 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 239000006260 foam Substances 0.000 description 13
- 238000002156 mixing Methods 0.000 description 11
- -1 polypropylene Polymers 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 9
- 201000009910 diseases by infectious agent Diseases 0.000 description 8
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 7
- 239000002002 slurry Substances 0.000 description 7
- 241001628273 Moina macrocopa Species 0.000 description 6
- 241000238590 Ostracoda Species 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 241000256173 Aedes albopictus Species 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000003641 microbiacidal Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 241000256118 Aedes aegypti Species 0.000 description 4
- 241000238571 Cladocera Species 0.000 description 4
- 229920002803 Thermoplastic polyurethane Polymers 0.000 description 4
- 230000001058 adult Effects 0.000 description 4
- 229910052586 apatite Inorganic materials 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 239000011164 primary particle Substances 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 239000011163 secondary particle Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 241000256111 Aedes <genus> Species 0.000 description 3
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 3
- 201000005807 Japanese encephalitis Diseases 0.000 description 3
- 241000710842 Japanese encephalitis virus Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000000749 insecticidal Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 229920002050 silicone resin Polymers 0.000 description 3
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 208000004293 Chikungunya Fever Diseases 0.000 description 2
- ZFSLODLOARCGLH-UHFFFAOYSA-N Cyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 2
- 208000001490 Dengue Diseases 0.000 description 2
- 206010012310 Dengue fever Diseases 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N Silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 208000007510 West Nile Fever Diseases 0.000 description 2
- 208000001455 Zika Virus Infection Diseases 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N [N-]=C=O Chemical compound [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000000823 artificial membrane Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 201000009182 chikungunya Diseases 0.000 description 2
- 201000002949 dengue disease Diseases 0.000 description 2
- QHZOMAXECYYXGP-UHFFFAOYSA-N ethene;prop-2-enoic acid Chemical compound C=C.OC(=O)C=C QHZOMAXECYYXGP-UHFFFAOYSA-N 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 230000003054 hormonal Effects 0.000 description 2
- 238000007561 laser diffraction method Methods 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 230000001699 photocatalysis Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 238000000790 scattering method Methods 0.000 description 2
- 150000003377 silicon compounds Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 125000005625 siliconate group Chemical group 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000000230 African Trypanosomiasis Diseases 0.000 description 1
- 240000000972 Agathis dammara Species 0.000 description 1
- 208000005067 Anisakiasis Diseases 0.000 description 1
- 241000256186 Anopheles <genus> Species 0.000 description 1
- 206010003486 Aspergillus infection Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N Bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 210000004369 Blood Anatomy 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 101700072555 CLEA Proteins 0.000 description 1
- 241001286462 Caio Species 0.000 description 1
- 240000005209 Canarium indicum Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infection Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002301 Cellulose acetate Polymers 0.000 description 1
- 201000003884 Chagas disease Diseases 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000725101 Clea Species 0.000 description 1
- 206010009344 Clonorchiasis Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000008953 Cryptosporidiosis Diseases 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- 241000256059 Culex pipiens Species 0.000 description 1
- 229920002871 Dammar gum Polymers 0.000 description 1
- 210000003298 Dental Enamel Anatomy 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N Diphenylmethane p,p'-diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- 206010014096 Echinococciasis Diseases 0.000 description 1
- 208000009366 Echinococcosis Diseases 0.000 description 1
- 206010014599 Encephalitis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229940023064 Escherichia coli Drugs 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000006275 Fascioliasis Diseases 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019143 Hantavirus pulmonary infection Diseases 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960002897 Heparin Drugs 0.000 description 1
- 208000006572 Human Influenza Diseases 0.000 description 1
- 206010022000 Influenza Diseases 0.000 description 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-N Isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 1
- 208000004554 Leishmaniasis Diseases 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- 206010024641 Listeriosis Diseases 0.000 description 1
- 206010025169 Lyme disease Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 208000005871 Monkeypox Diseases 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229940079938 Nitrocellulose Drugs 0.000 description 1
- 206010033794 Paragonimiasis Diseases 0.000 description 1
- 206010034107 Pasteurella infection Diseases 0.000 description 1
- 241000913680 Pectinodrilus molestus Species 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 229920001225 Polyester resin Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 208000003055 Prion Disease Diseases 0.000 description 1
- 229940055023 Pseudomonas aeruginosa Drugs 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037151 Psittacosis Diseases 0.000 description 1
- 206010037688 Q fever Diseases 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 206010039447 Salmonellosis Diseases 0.000 description 1
- 208000009434 Schistosomiasis japonica Diseases 0.000 description 1
- 206010039766 Scrub typhus Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N Sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229940076185 Staphylococcus aureus Drugs 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000736873 Tetraclinis articulata Species 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N Tetrafluoroethylene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 235000015450 Tilia cordata Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N Toluene diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- 208000003982 Trichinellosis Diseases 0.000 description 1
- 206010044608 Trichiniasis Diseases 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 206010045146 Tularaemia Diseases 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 229920002433 Vinyl chloride-vinyl acetate copolymer Polymers 0.000 description 1
- 229920001567 Vinyl ester Polymers 0.000 description 1
- 206010047461 Viral infection Diseases 0.000 description 1
- 208000001756 Virus Disease Diseases 0.000 description 1
- 201000006449 West Nile encephalitis Diseases 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 206010048249 Yersinia infection Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N Zirconium(IV) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 206010061417 Zoonotic bacterial infection Diseases 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2S,3R,4S,5R,6R)-2-[(2R,3R,4S,5R,6S)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2R,3R,4S,5R,6S)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000011354 acetal resin Substances 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000004931 aggregating Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229920003180 amino resin Polymers 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 201000002909 aspergillosis Diseases 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000004927 campylobacteriosis Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 201000007336 cryptococcosis Diseases 0.000 description 1
- 201000009861 cutaneous mycosis Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 239000004862 elemi Substances 0.000 description 1
- 201000000297 erysipelas Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 230000002538 fungal Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 201000005648 hantavirus pulmonary syndrome Diseases 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 201000006675 intestinal schistosomiasis Diseases 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 1
- 239000000025 natural resin Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 1
- HVWUMVBOAFDIFG-UHFFFAOYSA-K octacalcium;phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O HVWUMVBOAFDIFG-UHFFFAOYSA-K 0.000 description 1
- 201000000901 ornithosis Diseases 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000003071 parasitic Effects 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 201000003176 severe acute respiratory syndrome Diseases 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 201000002612 sleeping sickness Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000004083 survival Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 125000005628 tolylene group Chemical group 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 201000007588 trichinosis Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 229960005486 vaccines Drugs 0.000 description 1
- 201000001042 variant Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000017613 viral reproduction Effects 0.000 description 1
- 230000003612 virological Effects 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910052845 zircon Inorganic materials 0.000 description 1
- 229910052846 zircon Inorganic materials 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Abstract
A method for controlling a harmful insect is provided, the insect has little influence on the environment and is easily manipulated. As a result of in-depth studies, the present inventors found that a composite particle including a titanium oxide particle, a metal particle, and a calcium phosphate particle is contacted with a harmful insect or an egg thereof; or the composite particle is placed in the vicinity of the harmful insect or the egg, which makes it possible to effectively kill the harmful insect and control the harmful insect.
Description
Description Title of Invention: METHOD FOR CONTROLLING HARMFUL INSECTS
Technical Field
The présent invention relates to a method for controlling a harmful insect. More specifically, the présent invention relates to a method for controlling a harmful insect using a composite particle including a titanium oxide particle, a métal particle, and a calcium phosphate particle.
Background Art
In tropical areas to temperate areas in the world, it is estimated that about 720 million people still suffer from mosquito-bome infections per year, and 2 million to 4 million people of them die.
Vaccines and antiviral drugs which are effective in many infections are under development. In the présent condition, the development of methods for controlling vector mosquitoes is only an infection control method, and is expected. However, at présent, a method effective in mosquitoes is not found for 100 years or more after malaria is found to be borne by the mosquitoes.
- 2 As a mosquito combating method, for example, a method of Patent Literature 1 has been known. In the method, a juvénile hormone-like active compound or the like as an insect growth regulator is exposed to adults, and the adults lay eggs adjacent to water, so that larvae of the mosquitoes are combated. However, there are concems about the influence of the juvénile hormone-like active compound used in the method to the ecosystem.
Patent Literature 2 has been known as a method for preventing the occurrence itself of mosquitoes. The method relates to an apparatus for preventing the occurrence of the mosquitoes. The apparatus includes a water storing part including an upper surface opened to the atmosphère and a drain port provided in a bottom part thereof, a drain valve for opening and 10 closing the drain port, and means for driving and controlling the drain valve. In a day when water is stored in the water storing part, the water of the water storing part is drained by driving the drain valve after a predetermined length of time passes. However, the method requires a driving device, and the device has a complicated constitution, which is not realistic in a wide area where the mosquitoes occur.
In addition, a method for spraying an insecticide or applying an insect repellent such as a repellent to the skin is also general, and temporary. Continuous use of an organic compound which is an active ingrédient in many cases is far from being désirable from health and the influence of the organic compound on the environment.
- 3 Non-Patent Literature 1 describes earthplus (TM) manufactured and sold by Shinshu Ceramics Co., Ltd. (Nagano, Japan) as having microbicidal action on Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The earthplus is a powder of a composite material into which titanium oxide, silver, and hydroxyapatite are composited, and contains composite particles including one or more titanium oxide particles, one or more silver particles, and one or more hydroxyapatite particles. In the composite particle, one or more titanium oxide particles, one or more silver particles, and one or more hydroxyapatite particles are arranged three-dimensionally and randomly, and at least one silver particle is fixedly attached to at least one titanium oxide particle. The earthplus exerts microbicidal action based on the photocatalytic action of titanium oxide particles, the microbicidal action of silver particles, and the adsorbent action of hydroxyapatite particles. That is, the earthplus adsorbs microorganisms by the adsorbent action of hydroxyapatite particles and exerts microbicidal action on the microorganisms by the photocatalytic action of titanium oxide particles and the microbicidal action of silver particles.
However, no attention is paid to action on harmful insects such as mosquitoes, and the action is not disclosed or suggested.
Citation List
Patent Literatures
- 4 Patent Literature 1 : Japanese Patent Laid-Open No. 5-320001 Patent Literature 2: Japanese Patent Laid-Open No. 2003-144031
Non-Patent Literature
Non Patent literature 1 : Eriko Kasuga et al., Bactericidal activities of woven cotton and nonwoven polypropylene fabrics coated with hydroxyapatite-binding silver/titanium dioxide ceramic noncomposite Earth-plus, International Journal of Nanomedicine, 2011:6, pp.19371943
Summary of Invention
Technical Problem
It is an object of the présent invention to provide a method for controlling a harmfnl insect, which has little influence on the environment and is easily manipulated.
Solution to Problem
As a resuit of in-depth studies, the présent inventors found that a composite particle including a titanium oxide particle, a métal particle, and a calcium phosphate particle is contacted with a harmful insect or an egg thereof or the composite particle is placed in the vicinity of the harmful insect or the egg, which makes it possible to effectively kill the harmful
- 5 insect and control the harmful insect, thereby completing the présent invention. That is, the présent invention includes the following constitution.
(1) A harmful insect control method including: contacting a composite particle including a titanium oxide particle, a métal particle, and a calcium phosphate particle with a harmful insect or an egg thereof; or placing the composite particle in the vicinity of the harmful insect or the egg- (2) The method according to (1), wherein the harmful insect is a harmful insect bearing a zoonosis.
(3) The method according to (2), wherein the harmful insect bearing a zoonosis is a mosquito.
(4) The method according to any one of (1) to (3), wherein the contacting or placing step is performed in water.
(5) A harmful insect control member: having a composite particle including a titanium oxide particle, a métal particle, and a calcium phosphate particle on the member surface.
(6) The member according to (4), wherein the member is any one selected from a nonwoven fabric, a vessel, a manhole, a Street inlet, and a concrète product.
(7) The member according to (5) or (6), wherein the member is used in combination with water or in water.
(8) A harmful insect control coating material including: a composite particle including a titanium oxide particle, a métal particle, and a calcium phosphate particle.
(9) A harmful insect control agent including: a composite particle including a titanium oxide particle, a métal particle, and a calcium phosphate particle.
Advantageous Effects of Invention
The présent invention can control harmful insects. In particular, the hatch of eggs of mosquitoes can be controlled, and wrigglers, which are larvae of the mosquitoes, can be killed. Therefore, the spread of a mosquito-bome infection can be effectively prevented.
Brief Description of Drawings
[FIG. IA to FIG.1C] FIG. IA to FIG.1C show a photograph and an illustration diagram which show an egg laying vessel of mosquitoes of Test Example 1. FIG. IA shows an egg laying vessel of a test group, FIG. IB shows an egg laying vessel of a control group, and FIG. IC shows 15 height and length of filter paper.
Description of Embodiments (Living Subjects)
- 7 A method for controlling the hatch of eggs of mosquitoes using a composite particle has little influence on the environment and is easily manipulated. The présent method can kill harmful insects or control the hatch of eggs of harmfül insects including health insects and mites to control the harmful insects. Examples of subjects to be controlled include harmful insects including health insects bearing a zoonosis, and spécifie examples thereof include mosquitoes, moths, water fleas, mites, and eggs and larvae thereof.
Examples of the zoonosis include: bacterial zoonoses such as anthrax, plague, tuberculosis, pseudotuberculosis, pasteurellosis, salmonellosis, listeriosis, campylobacteriosis, leptospirosis, lyme disease, porcine erysipelas, bacillary dysentery, yersinia-enterocolitica infection, tularemia, rat-bite fever, and brucellosis; viral zoonoses such as influenza, SARS, rabies, West Nile fever, ebola hémorrhagie fever, marburg fever, B viral infection, Newcastle disease, Japanese encephalitis, tick encephalitis, hémorrhagie fever with rénal syndrome, hantavirus pulmonary syndrome, and monkeypox; rickettsia-coxiella-bartonella zoonoses such as Q fever, scrub typhus, and feline scratch disease; chlamydia zoonoses such as psittacosis;
protozoan zoonoses such as sleeping sickness, chagas disease, leishmaniasis, and cryptosporidium infection; parasitic zoonoses such as echinococcosis, schistosomiasis japonica, paragonimiasis, trichinosis, clonorchiasis, fascioliasis, and anisakiasis; fungal zoonoses such as cryptococcosis, candidiasis, aspergillosis, and cutaneous mycosis; and prion diseases such as variant Creutzfeldt-Jakob disease.
- 8 (Composite Particle)
The composite particle used in the présent invention includes one or more titanium oxide particles, one or more métal particles, and one or more calcium phosphate particles.
The number of titanium oxide particles per composite particle may be one or may be two or more. The number of titanium oxide particles per composite particle is usually two or more.
Examples of forms of the titanium oxide particle included in the composite particle include, but are not particularly limited to, globular, granular, acicular, flaky, and amorphous forms. The composite particle may include two or more titanium oxide particles having different forms.
The particle size of the titanium oxide particle included in the composite particle is not particularly limited as long as it is smaller than the particle size of the composite particle, and can be appropriately adjusted depending on the particle size of the composite particle. The titanium oxide particle included in the composite particle is, for example, a nanoparticle or a submicron particle.
Examples of crystal structures of the titanium oxide constituting the titanium oxide particle include an anatase type, a rutile type, and a brookite type, and among these, an anatase type is préférable.
- 9 The number of métal particles per composite particle may be one or may be two or more. The number of métal particles per composite particle is usually two or more.
Examples of forms of the métal particle included in the composite particle include, but are not particularly limited to, globular, granular, acicular, flaky, and amorphous forms. The composite particle may include two or more métal particles having different forms.
The particle size of the métal particle included in the composite particle is not particularly limited as long as it is smaller than the particle size of the composite particle, and can be appropriately adjusted depending on the particle size of the composite particle. The métal particle included in the composite particle is, for example, a nanoparticle or a submicron particle.
The métal particle included in the composite particle is, for example, selected from the group consisting of a silver particle, a gold particle, a platinum particle, and a copper particle. The métal particle included in the composite particle is preferably a silver particle. The composite particle may include two or more métal particles of different species.
The number of calcium phosphate particles per composite particle may be one or may be 15 two or more. The number of calcium phosphate particles per composite particle is usually two or more.
Examples of forms of the calcium phosphate particle included in the composite particle include, but are not particularly limited to, globular, granular, acicular, flaky, and amorphous
- 10 forms. The composite particle may include two or more calcium phosphate particles having different forms.
The particle size of the calcium phosphate particle included in the composite particle is not particularly limited as long as it is smaller than the particle size of the composite particle, and 5 can be appropriately adjusted depending on the particle size of the composite particle. The calcium phosphate particle included in the composite particle is, for example, a nanoparticle or a submicron particle.
Examples of calcium phosphates constituting the calcium phosphate particle include apatite, tricalcium phosphate, and octacalcium phosphate, and among these, apatite is préférable.
Examples of apatites include hydroxyapatite, apatite fluoride, and carbonate apatite, and among these, hydroxyapatite (Caio(P04)6(OH)2) is préférable.
The content of titanium oxide particles, métal particles, and calcium phosphate particles per composite particle is not particularly limited, and the lower limit value of the titanium oxide particle content is usually 10 parts by mass, preferably 20 parts by mass, more preferably 25 15 parts by mass, and still more preferably 30 parts by mass, relative to 1 part by mass of métal particles, and the upper limit value of the titanium oxide particle content is usually 300 parts by mass, preferably 250 parts by mass, more preferably 200 parts by mass, and still more preferably 180 parts by mass, relative to 1 part by mass of métal particles. The lower limit value of the calcium phosphate particle content is usually 1 part by mass, preferably 2 parts by mass, and
- 11 more preferably 3 parts by mass, relative to 1 part by mass of métal particles, and the upper limit value ofthe calcium phosphate particle content is usually 100 parts by mass, preferably 80 parts by mass, more preferably 60 parts by mass, and still more preferably 50 parts by mass.
The particle size of the composite particle as measured by dynamic light scattering is preferably 100 to 600 nm, more preferably 200 to 500 nm, and still more preferably 250 to 350 nm. Particle size measurement by dynamic light scattering is made by a commercially available dynamic light scattering type particle size distribution measuring device, preferably a dynamic light scattering type nano tracking particle size distribution measuring device, UPAEX150 (manufactured by Nikkiso Co., Ltd.).
In the composite particle, one or more titanium oxide particles, one or more métal particles, and one or more calcium phosphate particles are preferably arranged threedimensionally and randomly.
In one embodiment of the three-dimensional and random arrangement, at least one métal particle is fixedly attached to at least one titanium oxide particle.
In one embodiment of the three-dimensional and random arrangement, one or more particles (one or more particles selected from a titanium oxide particle, a métal particle, and a calcium phosphate particle) are présent around another particle (one particle selected from a titanium oxide particle, a métal particle, and a calcium phosphate particle). In this embodiment, one or more particles of the same species may be adjacent to a particle, and one or more particles
- 12 of different species may be adjacent to a particle. The adjacent particles are preferably bonded and fixedly attached to one another. Examples of combinations of adjacent particles include a combination between titanium oxide particles, a combination between métal particles, a combination between calcium phosphate particles, a combination between a titanium oxide particle and a métal particle, a combination between a titanium oxide particle and a calcium phosphate particle, and a combination between a métal particle and a calcium phosphate particle.
In one embodiment of the three-dimensional and random arrangement, a part of at least one particle selected from a titanium oxide particle, a métal particle, and a calcium phosphate particle is exposed at the surface of the composite particle.
10 ίη one embodiment of the three-dimensional and random arrangement, a part of at least one titanium oxide particle, a part of at least one métal particle, and a part of at least one calcium phosphate particle are exposed at the surface of the composite particle.
In one embodiment of the three-dimensional and random arrangement, at least one particle selected from a titanium oxide particle, a métal particle, and a calcium phosphate particle 15 is présent within the composite particle without being exposed at the surface of the composite particle.
In one embodiment of the three-dimensional and random arrangement, at least one particle selected from a titanium oxide particle, a métal particle, and a calcium phosphate particle has a membranous form and is présent at at least part of the surface of the composite particle.
- 13 In one embodiment of the three-dimensional and random arrangement, two or more particles selected from a titanium oxide particle, a métal particle, and a calcium phosphate particle are formed in one piece or in a row, having a membranous form, and are présent at at least part of the surface of the composite particle.
Whether a particle has a particulate form, has a membranous form, or forms a membranous form in one piece or in a row together with one or more of other particles may be influenced by the blending ratios of particles in the manufacture of the composite particles, and the like. Depending on the blending ratio, a particle may no longer maintain a particulate form but may take a membranous form présent at at least a part of the surface of the composite particle. For example, when particles are composited by a mechanical approach such as bead mill and bail mill, a particle (for example, silver particle) composed of a material having a lower hardness than other particles may take such a membranous form.
Two or more of the aforementioned embodiments about the three-dimensional and random arrangement may be combined.
As the composite particle, for example, a composite material powder sold by Shinshu
Ceramics Co., Ltd. under the trade name of earthplus can be used. The earthplus is a powder of a composite material into which titanium oxide, silver, and hydroxyapatite are composited, and contains a composite particle including one or more titanium oxide particles, one or more silver particles, and one or more hydroxyapatite particles. In the composite particle, one or
- 14 more titanium oxide particles, one or more silver particles, and one or more hydroxyapatite particles are arranged three-dimensionally and randomly, and at least one silver particle is fixedly attached to at least one titanium oxide particle. In the composite particle, a part of at least one titanium oxide particle, a part of at least one silver particle, and a part of at least one 5 hydroxyapatite particle are considered to be exposed at the surface of the composite particle.
The composite particle can be manufactured, for example, by using a wet mill to mix titanium oxide powder, a métal powder, and calcium phosphate powder in a liquid and compositing one or more titanium oxide particles included in the titanium oxide powder, one or more métal particles included in the métal powder, and one or more calcium phosphate particles 10 included in the calcium phosphate powder. The composite particle thus manufactured is used in the présent invention without being sintered.
The content (purity) of titanium oxide in the titanium oxide powder is preferably 90% by weight or more, more preferably 95% by weight or more, and still more preferably 98% or more. The upper limit value is, for example, 99%.
The particle size of the titanium oxide particle (primary particle) included in the titanium oxide powder is not particularly limited, and it is, for example, 0.03 to 0.1 pm. Because wet mills can make a particle aggregate into individual dispersed particles, the titanium oxide powder may include an aggregate (secondary particle) of titanium oxide particles. The particle size of an aggregate of titanium oxide particles is, for example, 1 to 2 pm. The particle size of a
- 15 titanium oxide particle or an aggregate thereof is measured, for example, using a transmission électron microscope (TEM) or a scanning électron microscope (SEM).
The métal content (purity) of the métal powder is preferably 80% by weight or more, more preferably 95% by weight or more, and still more preferably 98% or more. The upper 5 limit value is, for example, 99.9%.
The particle size of the métal particle (primary particle) included in the métal powder is not particularly limited, and it is, for example, 1.1 to 1.9 pm. Because wet mills can make a particle aggregate into individual dispersed particles, the métal powder may include an aggregate (secondary particle) of métal particles. Keeping a métal powder refrigerated until it is used can 10 control the aggregation of métal particles included in the métal powder. The particle size of a métal particle or an aggregate thereof is calculated, for example, based on the spécifie surface area.
The calcium phosphate content (purity) of the calcium phosphate powder is preferably 90% by weight or more, more preferably 95% by weight or more, and still more preferably 98% 15 or more.
The particle size of the calcium phosphate particle (primary particle) included in the calcium phosphate powder is not particularly limited, and it is, for example, 0.1 to 0.2 pm. Because wet mills can make a particle aggregate into individual dispersed particles, the calcium phosphate powder may include an aggregate (secondary particle) of calcium phosphate particles.
- 16 The particle size of an aggregate of calcium phosphate particles is, for example, 4 to 5 pm. The particle size of a calcium phosphate particle or an aggregate thereof is measured by, for example, a laser diffraction/scattering method.
Wet mills can composite one or more titanium oxide particles, one or more métal particles, 5 and one or more calcium phosphate particles while dispersing and pulverizing, in a liquid, particles included in titanium oxide powder, a métal powder, and calcium phosphate powder. Examples of wet mills include bead mills and bail mills, and among these, bead mills are préférable. Examples of materials of pulverizing media, such as beads and balls, to be used in mills such as bead mills and bail mills include alumina, zircon, zirconia, Steel, and glass, and among these, zirconia is préférable. The size (diameter) of pulverizing media can be appropriately adjusted depending on the particle size of a composite particle to be manufactured, and the like, and is usually 0.05 to 3.0 mm, and preferably 0.1 to 0.5 mm. As pulverizing media, for example, beads or balls having a size of about 0.1 mm and a mass of about 0.004 mg can be used.
The liquid used in mixing is, for example, an aqueous medium such as water. When the liquid used in mixing is water, the total amount of titanium oxide powder, a métal powder, and calcium phosphate powder blended is adjusted so as to be usually 25 to 45 parts by mass, and preferably 30 to 40 parts by mass, relative to 65 parts by mass of water.
- 17 When raw materials including titanium oxide powder, a métal powder, calcium phosphate powder, and a liquid are mixed in a wet mill, varions conditions, for example, the total amount of raw material powders added, the flow rate of the liquid, the circumferential speed of the blades within the cylinder, the stirring température, and the stirring time and the like can be appropriately adjusted depending on the particle size of a composite particle to be manufactured, and the like. The total amount of raw material powders (titanium oxide powder, a métal powder, and calcium phosphate powder) added is, for example, 4 kg or more; the cylinder volume is, for example, 0.5 to 4 L; the flow rate of the liquid is, for example, 0.5 to 3 L/minute; the circumferential speed of the blade is, for example, 300 to 900 m/minute; the liquid température is, for example, 20 to 60°C; and the mixing time per 1 kg of raw material powder is, for example, 0.5 to 2 hours. The upper limit value of the total amount of raw material powders added can be appropriately adjusted depending on the cylinder volume and the like. The mixing time can be appropriately adjusted depending on the total amount of raw material powders added, and the like.
In addition to titanium oxide powder, a métal powder, calcium phosphate powder, and a liquid, a dispersant is preferably added to the raw materials. Examples of dispersants include a high molecular weight type dispersant, a low molecular weight type dispersant, and an inorganic type dispersant, and a sélection can be appropriately made depending on the kind of the liquid used in wet mixing. When the liquid used in mixing is an aqueous medium such as water, for
- 18 example, an anionic high molecular weight type dispersant and a nonionic high molecular weight type dispersant and the like can be used as a dispersant; examples of anionic high molecular weight type dispersants include a polycarboxylic acid dispersant and a formalin naphthalenesulfonate condensate type dispersant; and examples of nonionic high molecular weight type dispersants include polyethylene glycol. The amount of a dispersant added may be appropriately adjusted, and is, for example, 0.1 to 3% by mass, and preferably 0.3 to 1% by mass, relative to 35 parts by mass of the total amount of titanium oxide powder, a métal powder, and calcium phosphate powder blended.
A suspension (slurry) of composite particles can be manufactured by using a wet mill to mix titanium oxide powder, a métal powder, and calcium phosphate powder in a liquid and compositing one or more titanium oxide particles included in the titanium oxide powder, one or more métal particles included in the métal powder, and one or more calcium phosphate particles included in the calcium phosphate powder. Then, the solvent in the suspension is removed by évaporation or the like, whereby an assembled product (dry powder) of composite particles can be manufactured. An assembled product (dry powder) of composite particles can also be manufactured from a suspension (slurry) of composite particles by a known granulation method such as spray dry granulation.
- 19 The particle size of an assembled product of composite particles, as measured by dynamic light scattering, is, for example, 100 to 600 nm, and preferably 200 to 500 nm. The médian diameter (d50) of an assembled product of composite particles, as measured by dynamic light scattering on a volumétrie basis, is, for example, 250 to 350 nm, and preferably about 300 nm.
A particle size by dynamic light scattering is measured using a commercially available dynamic light scattering type particle size distribution measuring device, and preferably a dynamic light scattering type nano tracking particle size distribution measuring device, UPA-EX150 (manufactured by Nikkiso Co., Ltd.).
The manufactured composite particles can be used in the présent invention as they are, and the particle size may be adjusted before being used in the présent invention. The adjustment of the particle size can be carried out, for example, by sieving composite particles in the powder State or in the suspension State.
In the assembled product of composite particles, the respective numbers of titanium oxide particles, métal particles, and calcium phosphate particles per composite particle may be identical or different among the composite particles.
In addition to the composite particles including one or more titanium oxide particle, one or more métal particle, and one or more calcium phosphate particle, other particles which may be produced as byproducts in the manufacture of the composite particles may coexist in the assembled product of composite particles. Examples of the other particles include an
- 20 independent titanium oxide particle, an independent métal particle, an independent calcium phosphate particle, a bonded product of titanium oxide particles (including no métal particle and no calcium phosphate particle), a bonded product of métal particles (including no titanium oxide particle and no calcium phosphate particle), a bonded product of calcium phosphate particles (including no titanium oxide particle and no métal particle), a bonded product of a titanium oxide particle and a métal particle (including no calcium phosphate particle), a bonded product of a titanium oxide particle and a calcium phosphate particle (including no métal particle), and a bonded product of a métal particle and a calcium phosphate particle (including no titanium oxide particle).
(Method for Contacting Composite Particle with Harmful Insect or Placing Composite Particle in Vicinity of Harmful Insect)
The method for contacting a composite particle with a harmful insect according to the présent invention may be any method as long as the method causes the composite particle of the présent invention to be présent in the habitat of the harmful insect or an egg thereof. Examples 15 of the method for causing the composite particle to be présent in the habitat include a method for placing the composite particle as a member in the habitat. There is a method for applying, bonding, attaching, and fixing a composite particle to a member which has been already présent in the habitat, to cause the composite particle to be présent.
- 21 The kind of the member may be any as long as the member can hold the composite particle of the présent invention, and examples thereof include a breathable sheet member such as a nonwoven fabric, a building wall, particularly an outer wall, a drainage channel, a rainwater measure, a manhole inner part, a manhole lid, a U-shaped groove, a construction member, a building material, gravel, a filter material, a resin such as foamed polystyrène dropped to a puddle, and paper.
The présent invention includes indirect contact via a medium by placing these members in the vicinity of harmful insects or eggs of the harmful insects even in a non-contact State in addition to the direct contact of the members with the harmful insects or the eggs of the harmful insects. As an example, the vicinity means that underwater lives such as wrigglers and water fleas swim to be in the vicinity of the composite particle when a member to which the composite particle of the présent invention is attached is installed in water. In this case, the underwater lives are contacted with the member via a water medium. The degree of the vicinity is preferably 5 cm or less, more preferably 3 cm or less, still more preferably 1 cm or less, and most preferably 5 mm or less. That is, a harmful insect control member including the composite particle of the présent invention is also preferably used in combination with water or in water.
According to the présent invention, it is considered that the harmful insects or the eggs of the harmful insects are contacted with, or placed in the vicinity of the composite particle,
- 22 whereby the living body is subjected to any damage by the action derived from the particle and the interaction between the particle and the living body to provide the extinction, the control of egg laying, and the control of the hatch of the eggs although the action mechanism is not necessarily apparent.
Examples of a method for applying the composite particle of the présent invention to each member include a method for attaching the composite particle to the completed member afterward, and a method for adding the composite particle to raw materials of the member to manufacture the member. Examples of the attaching method include a method for mixing the composite particle with a binder resin or the like to attach the composite particle to the member.
Examples of a method for attaching the composite particle to a concrète include a method for coating a binder resin including the composite particle on the concrète.
The material of the member may be any as long as the composite particle can be fixed to the member. Among these, a porous body is désirable. The pore diameter of the porous body is preferably several micrometers to tens of micrometers. It is désirable that the water pénétration speed of the porous body is not so high.
Examples of the material of the member include a concrète, an asphalt, a ceramic, a sponge, a nonwoven fabric, a resin such as foam polystyrène, and paper.
- 23 Hereinafter, an example in which the composite particles of the présent invention is attached to a breathable sheet member via a binder resin will be described as a typical example, but the member can be used for any of those described above.
A breathable sheet member to which the composite particles are attached via a binder resin can be manufactured by supplying a mixed solution containing the composite particles and a binder resin to a breathable sheet member or immersing a breathable sheet member in a mixed solution containing the composite particles and a binder resin, followed by drying the breathable sheet member. A breathable sheet member to which the composite particles are attached via a binder resin can be manufactured by supplying a mixed solution containing the composite particles and a binder resin to the raw fabric of a breathable sheet or immersing the raw fabric of a breathable sheet in a mixed solution containing the composite particles and a binder resin, followed by drying the raw fabric of the breathable sheet and then cutting a breathable sheet member out of the raw fabric of the breathable sheet.
The amount of the binder resin contained in the mixed solution is preferably 20 to 90 parts by mass, more preferably 30 to 85 parts by mass, and still more preferably 40 to 80 parts by mass, relative to 100 parts by mass of the composite particles. The amount of the binder resin contained in the breathable sheet member is similar.
- 24 The total amount of the composite particles and binder resin attached per unit area of the breathable sheet member is not particularly limited, and the lower limit value of the total amount attached is usually 2 g/m2, preferably 3 g/m2, more preferably 4 g/m2, still more preferably 5
2 g/m , and still more preferably 6 g/m , and the upper limit value of the total amount attached is usually 30 g/m2, preferably 25 g/m2, more preferably 20 g/m2, and still more preferably 15 g/m2.
Preferred examples of the amount attached include the same amount attached when the mixed solution is applied to other members such as a concrète.
For the binder resin, known resins having adhesiveness may be used singly or in combinations of two or more thereof. Examples of the binder resin include: natural thickening agents or natural resins such as gelatin, gum arabic, shellac, dammar, elemi, and sandarac; semisynthetic thickening agents or semisynthetic resins such as methyl cellulose, ethyl cellulose, nitro cellulose, carboxymethyl cellulose, and acetate; isophthalic acid-based, terephthalic acidbased, bisphenol-based, and vinyl ester-based polyester resins; acrylic copolymer resins such as ethylene acrylic acid, ethylene acrylic acid ester, acryl ester vinyl, and methacrylic acid ester vinyl; urethane resins formed from the reaction of isocyanate dérivative or isocyanurate dérivative such as tolylene dicysocyanate, 4,4'-diphenylmethanediisocyanate, or lysine ester triisocyanate, isocyanate dérivative or isocyanurate dérivative such as tolylene diisocyanate, and polyol such as polyester polyol, polyether polyol, acrylloylol, or phenolic polyol; halogenated polymers such as polyvinyl chloride and polyvinylidene chloride; acetal resins such as polyvinyl
- 25 acetate, ethylene-vinyl acetate copolymer, vinyl chloride-vinyl acetate copolymer, polyacryl ester, polystyrène, and polyvinyl acetal; polycarbonate resins; cellulose resins such as cellulose acetate; polyolefin resins; synthetic thickening agents or synthetic resins of amino resins and the like such as urea resin, melamine resin, and benzoguanamine resin; silicone resins including a modified product, such as an epoxy-modified, amino-modified, urethane-modified, alkydmodified, or acryl-modified product, a copolymer, and the like, including silicone resins such as polyalkyl siloxane, polyalkyl hydrogen siloxane, polyalkylalkenyl siloxane, polyalkyl siliconate, polyalkalialkyl siliconate, and polyalkylphenyl siloxane; and fluorine resins such as polymers such as tetrafluoro ethylene or vinylidene fluoride, copolymers of these monomers and another monomer. Among these, urethane resins and silicone resins are préférable, and urethane resins are particularly préférable, from the viewpoint of adhesiveness and the like. The binder resin applied to a concrète is preferably an acrylic copolymerization resin, and Tonan-bond (manufactured by Tonan-bond Co., Ltd.) can be exemplifïed.
Inorganic binders instead of or in combination of the binder resins may be used singly or in combinations of two or more thereof. Examples of the inorganic binders include products obtained by decomposing hydrolysable Silicon compounds such as alkyl silicate, halogenated Silicon, and partial hydrolysate thereof; organic polysiloxane compounds and polycondensates thereof; phosphates such as silica, colloïdal silica, water glass, Silicon compound, and zinc
- 26 phosphate; métal oxides such as zinc oxide and zirconium oxide; biphosphates; cements; gypsums; limes; and frits for enamel.
A harmful insect control agent which contains the composite particle including a titanium oxide particle, a métal particle, and a calcium phosphate particle of the présent invention as an active ingrédient may be the composite particle itself, and may contain other known ingrédients as long as a harmful insect control operation of the présent invention is not impaired. Examples of the other known ingrédients include other insecticidal components. Of course, the harmful insect control method can be used in combination with other known harmful insect combating method and harmful insect control method. For example, the harmful insect control agent of the présent invention can also be applied to other mosquito capturing tools. Since mosquitoes prefer water places and carbon dioxide, the harmful insect control agent is also effectively combined with a carbon dioxide génération method and the presence of water as in Test Examples to be described later.
EXAMPLES
Hereinafter, the présent invention will be described in further detail with reference to
Manufacturing Examples and Test Examples. However, the scope of the présent invention is not limited to these Manufacturing Examples and Test Examples.
Manufacturing Example 1 : Manufacture of Composite Particles
- 27 In the présent Manufacturing Example, titanium oxide powder, silver powder, and hydroxyapatite power were used as raw material powders. And composite particles including one or more titanium oxide particles, one or more silver particles, and one or more hydroxyapatite particles were manufactured.
In the présent Manufacturing Example, two composite particles Ml and M2 were manufactured. The composite particles Ml and M2 were different in the content ratio of titanium oxide, silver, and hydroxyapatite. The composite particles Ml and M2 were manufactured in the same manner as earthplus (TM) manufactured and sold by Shinshu Ceramics Co., Ltd. (Nagano, Japan). The manufacture of the composite particles Ml and M2 10 was consigned to Shinshu Ceramics Co., Ltd.
The raw material powders shown in Table 1 were prepared. The particle size of the titanium oxide powder is a value measured using a transmission électron microscope (TEM) or a scanning électron microscope (SEM). The particle size of the silver powder is a value calculated based on the spécifie surface area. The particle size of the hydroxyapatite powder is 15 a value measured by a laser diffraction/scattering method. The silver particles contained in the silver powder were inhibited from aggregating because the silver powder was kept refrigerated until it was used.
- 28 [Table 1]
Raw material powder
| Anatase type titanium oxide powder | Hydroxyapatite powder | Silver powder | |
| CAS No. | 13463 - 67-7 | 10103 -46 -5 | 7440 - 22 - 4 |
| Purity | 95% by weight or | 95% by weight or | 95% by weight or |
| more | more | more | |
| Shape | Powder | Powder | Powder |
| Color | White | White | - |
| Smell | None | None | None |
| Spécifie gravity | 3.9 | 2.7 | 10.5 |
| Particle size of primary particle | 0.03 - 0.1 pm | 0.1 - 0.2 pm | 1.1 - 1.9 pm |
| Particle size of secondary particle | 1-2 pm | 4-5 pm | - |
| pH | 6-8 | - | - |
| Melting point | 1823°C or higher | 1670°C or higher | 962°C or higher |
A commercially available wet bead mill (STARMILL LME manufactured by Ashizawa
Finetech Ltd.) was used to mix titanium oxide powder, silver powder, hydroxyapatite powder, and a polycarboxylic acid dispersant in water, thereby compositing one or more titanium oxide particles included in the titanium oxide powder, one or more silver particles included in the silver powder, and one or more hydroxyapatite particles included in the hydroxyapatite powder, to manufacture a suspension (slurry) of composite particles. The wet bead mill used can
- 29 pulverize titanium oxide particles, silver particles, and hydroxyapatite particles included in the raw material powder while dispersing them, whereby they can be made into fine particles as small as nanoparticles or submicron particles, and the fine particles can be composited.
The conditions for compositing particles using the wet bead mill were as follows:
the total amount of raw material powder added: 4 kg or more cylinder volume: 3.3 L beads: beads made of zirconia (0.5 mm in diameter, 0.37 mg in mass) flow rate of liquid: 2 L/minute circumferential speed of blades in cylinder: 540 m/minute liquid température: 35 to 45°C mixing time per kg of raw material powder: 30 to 40 minutes (about 36 minutes)
The total amount of titanium oxide powder, silver powder, and hydroxyapatite powder blended was adjusted to 35 parts by mass relative to 65 parts by mass of water. The amount of polycarboxylic acid dispersant blended was adjusted to 0.5 parts by mass relative to 35 parts by 15 mass of the total amount of titanium oxide powder, silver powder, and hydroxyapatite powder blended.
In the manufacture of the composite particles Ml, the amount of titanium oxide powder blended was adjusted to about 160 parts by mass (155 to 165 parts by mass) relative to 1 part by mass of silver powder; and
- 30 the amount of hydroxyapatite powder blended was adjusted to about 40 parts by mass (39 to 41 parts by mass) relative to 1 part by mass of silver powder.
In the manufacture of the composite particles M2, the amount of titanium oxide powder blended was adjusted to about 30 parts by mass (29 to 31 parts by mass) relative to 1 part by mass of silver powder, and the amount of hydroxyapatite powder blended was adjusted to about 3 parts by mass (2.5 to 3.5 parts by mass) relative to 1 part by mass of silver powder.
The composite particles Ml and M2 were manufactured by drying a suspension (slurry) of composite particles. The particle size of composite particles Ml and M2, as measured by dynamic light scattering, was 200 to 500 nm. The médian diameter (d50) of the composite particles Ml and M2, as measured by dynamic light scattering on a volumétrie basis, was about 300 nm. The particle size by dynamic light scattering was measured using a commercially available dynamic light scattering type particle size distribution measuring device, specifically a dynamic light scattering type nano tracking particle size distribution measuring device, UPAEX150 (manufactured by Nikkiso Co., Ltd.),
[Test Example 1] Hatch Control Test of Eggs of Mosquitoes by Composite Particle of Présent Invention
In the présent Test, mosquitoes were caused to lay eggs on a filter paper treated by the composite particle of the présent invention; and the number of the eggs hatched was compared
- 31 with that of an untreated control group to investigate the influence of the composite particle of the présent invention on the hatch of the eggs of the mosquitoes.
1. Test Method
-1. Material (1) Egg Laying Vessel (i) Test Group mL of Milli-Q water and 20 pL of the Ml particle solution were added into a 250-mL plastic vessel (12 cm in diameter, 7 cm in height) (the last concentration of the Ml particle: 0.014%). Next, an egg laying filter paper (4 cm in height, 9 cm in length) was stuck on an inner wall surface of the plastic vessel, which was taken as a test group (FIG. 1 A, FIG. 1C). 1 cm of the height of the egg laying filter paper is below a water surface, and 3 cm of the height of the filter paper is in a wet State in the air. The eggs were laid on a wetter filter paper portion on the boundary (that is, water's edge) between a water layer and an air layer.
(ii) Control Group
The same as the test group was taken as the control group except that 50 mL of MiliQ water including no composite particle of the présent invention was added into a 250-mL plastic vessel (FIG. IB).
(2) Mosquitoes
- 32 150 Aedes albopictus adults collected in a house in Hatsudai, Shinjuku-ku, Tokyo and passaged in the laboratory and 150 Aedes aegypti adults imparted by the University of Notre Dame in the U.S. were used. Examples of the Aedes albopictus-bome infection include Zika virus infection, dengue fever, Chikungunya fever, West Nile fever, and Japanese encephalitis and the like. The vector mosquitoes of the West Nile fever are Culex pipiens (Cx. p. molestus, Cx. p. pallense) having blood-sucking palatability from birds, but the Aedes albopictus is also known to participate in the infection as a bridge vector mosquito. The main vector mosquito of the Japanese encephalitis is Culex tritaeniorhyncus, but the Aedes albopictus is also known to be experimentally infected. Examples of the Aedes aegypti-bome infection include Zika virus infection, dengue fever, Chikungunya fever, and yellow fever.
1-2. Test Procedure (1) Blood-Sucking of Mosquitoes
Aedes aegypti and Aedes albopictus were placed into different cloth adult cages (20 x 20 x 30 cm), respectively, and heparin-containing horse whole blood was sucked via an artificial membrane with an artificial membrane feeding system manufactured by Hemotek Ltd. The adult gauges were installed in a humidifier at 37°C.
(2) Egg Laying of Mosquitoes
- 33 The egg laying vessels of the test group and control group were installed in the adult cage immediately after blood-sucking. Then, the adults were waited to lay eggs on a wet filter paper in a constant température bath at 24°C (lighting time per day: 16 hours, dark time: 8 hours).
(3) Treatment of Laid Eggs
Since the eggs were confirmed on the wet egg laying filter paper in each of the egg laying vessels of the test group and control group after six days from blood-sucking, the vessel was removed from the adult cage, covered, and allowed to stand at 24°C for three days.
Then, the filter paper on which the eggs were laid was immersed in water in the same egg 10 laying vessel. As a diet for larvae, a CE-2 powder feed (manufactured by CLEA Japan, Inc.) was dissolved in an appropriate quantity of water and given.
(4) Count of Number of Hatched Larvae and Eggs
In order to confirm the hatch of the larvae, the presence or absence of the hatch was observed for about two weeks, and the number of the hatched larvae was counted. The number 15 of the eggs on the egg laying filter paper was counted at the end of the test.
The Fisher's exact test was employed.
2. Test Results
- 34 Regarding the Aedes albopictus, the number of the eggs laid on the egg laying filter paper treated by the composite particle of the présent invention of the test group was 250, and the number of the eggs hatched among these was 45 (hatch rate: 18%). Meanwhile, in the control group, the number of the eggs laid on the untreated egg laying fdter paper was 170, and the number of the eggs hatched among these was 148 (hatch rate: 87%). The odds ratio was 0.033 (95% credibility interval: 0.019, 0.057).
Regarding the Aedes aegypti, the number of the eggs laid on the egg laying filter paper treated by the composite particle of the présent invention of the test group was 75, and the number of the eggs hatched among these was 12 (hatch rate: 16%). Meanwhile, in the control 10 group, the number of the eggs laid on the untreated egg laying filter paper was 51, and the number of the eggs hatched among these was 32 (hatch rate: 62.7%). The odds ratio was 0.113 (95% credibility interval: 0.049, 0.262).
As described above, it was found that the composite particle of the présent invention can significantly control the hatch rate of the mosquitoes regardless of the kinds of the mosquitoes. 15
[Table 2]
| Kinds of mosquitoes | Numbe r of eggs | Number of eggs hatched | Hatch rate | Significa nt differenc e | Odds ratio | |
| Aedes | Test group | 250 | 45 | 18% | Presence | 0.033 |
| albopictus | Control group | 170 | 148 | 87% | ||
| Aedes aegypti | Test group | 75 | 12 | 16% | Presence | 0.113 |
| Control group | 51 | 32 | 63% |
[Test Example 2] Harmful Insect Control Test by Composite Particle of Présent Invention (Indoor)
In the présent Test, microorganisms were caused to swim in a cultivation vessel coated with a binder including the composite particle of the présent invention to investigate the influence of the composite particle of the présent invention on the survival of the microorganisms.
1. Test Method
1-1. Material ( 1 ) Cultivation Vessel
A slurry obtained by mixing the composite particle Ml of the présent invention, a binder (product name: Tonan-bond), and water at a ratio of 1 : 1 : 1 was uniformly applied to an unglazed cultivation vessel (volume: 30 to 50 ml) by a brush. The cultivation vessel was allowed to stand at normal température for 12 hours, and dried to préparé a test cultivation vessel.
A slurry including a binder and water at 1 : 1 was similarly applied to an unglazed cultivation vessel to préparé a control cultivation vessel.
(2) Microorganisms
Moina macrocopas, ostracods, and mosquito larvae were collected from a pond of a private house in Aso-ku, Kanagawa.
1-2. Test Method (1) Control Group
Water of the pond was placed into the control cultivation vessel, and four Moina macrocopas and four ostracods were charged into the control cultivation vessel.
(2) Test Group 1
Water of the pond was placed into the test cultivation vessel, and 15 Moina macrocopas and three ostracods were charged into the test cultivation vessel.
(3) Test Group 2
Water of the pond was placed into the test cultivation vessel, and 30 Moina macrocopas, eight ostracods, and eight mosquito larvae were charged into the test cultivation vessel.
All the tests were performed at room température (about 26°C).
2. Test Results (1) Control Group
Even after ten days had elapsed from the start of the test, all the water fleas vigorously swam.
(2) Test Group 1
After three hours from the start of the test, ail the Moina macrocopas died, and after one day, ail the ostracods died.
(3) Test Group 2
After four hours from the start of the test, ail the Moina macrocopas died; after one day, ail the ostracods died; and after 15 days, six mosquito larvae died, and after 28 days, ail the mosquito larvae died.
As described above, the composite particle of the présent invention was found to hâve an insecticidal effect on the water fleas and the mosquito larvae.
[Test Example 3] Harmful Insect Control Test by Composite Particle of Présent Invention (Outdoor)
In the présent test, at the following test place, water was placed into a vessel coated with a binder including the composite particle of the présent invention, and the effect of controlling mosquito larvae and mosquitoes by the composite particle of the présent invention was investigated over a long time period.
1. Test Method
1-1. Material (1) Vessel (a) Concrète Vessel of Test Group 1
About 25 ml of 90 ml of a mixed solution of 30 ml of a composite particle solution (i) of the présent invention, 30 ml of a binder solution (ii), and 30 ml of water which will be described later was coated (applied) to a height of about 15 cm on the whole of an inner surface of a cylindrical concrète vessel including an opened upper part (45 cm in inner diameter, 19 cm in height, 30 L in volume capacity) by a brush, and allowed to stand at normal température for three days for drying, to préparé a test vessel.
(i) The composite particle solution is an aqueous solution including 35% by weight of a composite particle Ml of the présent invention.
(ii) The binder solution is obtained by dissolving Tonan-bond (product name) (manufactured by Tonan-bond Co., Ltd.) in a tiny amount of water.
(b) Concrète Vessel of Test Group 2
The concrète vessel of the test group 2 was prepared in the same manner as in the concrète vessel of the test group 1 except that 180 ml of a mixed solution of 30 ml of the composite particle solution (i), 30 ml of the binder solution (ii), and 120 ml of water was used as the mixed solution applied to the concrète vessel.
(c) Concrète Vessel of Control Group
- 39 The concrète vessel of the control group was prepared in the same manner as in the concrète vessel of the test group 1 except that 60 ml of a mixed solution of 30 ml of the binder solution (ii) and 30 ml of water was used.
1-2. Test Method
24 L of Tap water was placed into each of one concrète vessel of the control group, three concrète vessels of the test group 1, and six concrète vessels of the test group 2. These vessels were allowed to stand for about one year under a vinyl sheet tent, and the number of the mosquito larvae per month from the fourth month was counted. The water in each of the vessels was replaced after counting on the seventh month. The tent had only a roof, and was in a state where a side surface was exposed to the open air. Lower surfaces of the vessels were placed on wooden floor grates having a height of about 5 cm so that the vessels were not directly contacted with the ground.
1-3. Test Place
Tokawa, Hadano-shi, Kanagawa
1-4. Test Period
For one year after December 5, 2017. A température during the test period was 3°C to 35°C.
2. Test Results
- 40 The results are shown in Table 3. In the test group 1 and test group 2 to which the binder including the composite particle of the présent invention was applied, the mosquito larvae hardly occurred over one year. Meanwhile, in the control group to which the composite particle of the présent invention was not applied, 80 mosquito larvae occurred.
As described above, the composite particle of the présent invention was found to hâve the effect of controlling the egg laying of the mosquitoes to significantly control the mosquito larvae.
[Table 3]
| Control group (one vessel) | Test group 1 | Test group 2 | |||
| Total number for three vessels (mosquito larvae) | Average value per vessel (mosquito larvae) | Total number for six vessels (mosquito larvae) | Average value per vessel (mosquito larvae) | ||
| April 12, 2018 (about four months from start of test) | 20 | 0 | 0 | 0 | 0 |
| May 17 | 30 | 4 | 1 | 2 | 1 |
| June 19 | 6 | 2 | 1 | 1 | 1 |
| July 19 | 0 | 2 | 1 | 0 | 0 |
| August 7 | 0 | 0 | 0 | 0 | 0 |
| September 3 | 5 | 2 | 1 | 0 | 0 |
| September 26 | 15 | 0 | 0 | 0 | 0 |
| October 23 | 80 | 14 | 5 | 0 | 0 |
- 41 *The average value per vessel is represented by an integer obtained by rounding up a value obtained by dividing the total number of the mosquito larvae in ail the vessels by the number of the vessels.
[Test Example 4] Manufacture of Harmful Insect Control Member
The effects were confirmed in the filter paper impregnated with the composite particle solution of the présent invention in the above Test Example 1, and the vessel coated with the binder including the composite particle in each of Test Example 2 and Test Example 3. In addition, the same effect can be expected also in a nonwoven fabric and foam polystyrène to which HAIDOROGINCHITAN (Hyd[AgTiO2]) is fixed.
1. Manufacture of Composite-Particles-Attached Nonwoven Fabric
To the suspension (slurry) of the composite particles Ml obtained in Manufacturing Example 1, a binder resin was added to préparé a mixed solution, whereafter a spunpond nonwoven fabric made of polyester was immersed in the mixed solution, thereby impregnating the nonwoven fabric with the mixed solution. Aller the immersing, the nonwoven fabric was removed from the mixed solution and pressed with a roller to squeeze out the surplus mixed solution. After the pressing, the nonwoven fabric was dried at about 130°C for about one minute to manufacture a composite-particles-attached nonwoven fabric NI. As a binder resin, a urethane resin (C3H7NO2/NH2COOC2H5) was used.
- 42 By adjusting the concentrations of the composite particles Ml and the binder resin in the mixed solution, the total amount of composite particles Ml and binder resin attached (fixed) per unit area of the composite-particles-attached nonwoven fabric NI was adjusted to 4 g/m2, 6 g/m2, 8 g/m2, or 10 g/m2.
22
The breakdown of 4 g/m was 2.27 g/m of titanium oxide, 0.571 g/m of hydroxyapatite,
0.014 g/m of silver, and 1.14 g/m of binder resin.
92
The breakdown of 6 g/m was 3.41 g/m- of titanium oxide, 0.857 g/m of hydroxyapatite, 0.021 g/m2 of silver, and 1.71 g/m2 of binder resin.
The breakdown of 8 g/m2 was 4.54 g/m2 of titanium oxide, 1.143 g/m2 of hydroxyapatite, 10 0.029 g/m2 of silver, and 2.29 g/m2 of binder resin.
2 2
The breakdown of 10 g/m was 5.68 g/m of titanium oxide, 1.428 g/m of hydroxyapatite,
2
0.036 g/m of silver, and 2.86 g/m- of binder resin.
A composite-particles-attached nonwoven fabric N2 was manufactured in the same manner as described above, except that a suspension of composite particles M2 was used in 15 place of the suspension of the composite particles Ml.
By adjusting the concentrations of the composite particles M2 and the binder resin in the mixed solution, the total amount of composite particles M2 and binder resin attached (fixed) per unit area of the composite-particles-attached nonwoven fabric N2 was adjusted to 13.5 g/m2.
- 43 The breakdown of 13.5 g/m2 was 6.525 g/m2 of titanium oxide, 0.750 g/m2 of hydroxyapatite, 0.225 g/m2 of silver, and 6.00 g/m2 of binder resin.
2. Manufacture of Composite-Particles-Attached Foam Polystyrène Sheet or Foam Polystyrène
Beads
The composite particles Ml or M2 of the présent invention were mixed with raw materials of foam polystyrène to manufacture composite-particles-attached foam polystyrène and foam polystyrène beads.
3. Utilizing Method (1) limer Wall Surface of Vessel is Covered with Nonwoven Fabric
The nonwoven fabric NI or N2 of the above item 1. was stuck on an inner wall surface of a vessel into which water was placed, and installed so that the lower part thereof was immersed in water. Many of mosquitoes laid eggs on the wall close to the surface of the water, so that the 15 mosquitoes laid eggs on the nonwoven fabric which was stuck on the inner wall and was close to the surface of the water. Therefore, the eggs were contacted with the composite particles in the nonwoven fabric to control the hatch of the eggs.
(2) Nonwoven Fabric is Randomly Inserted into Water
- 44 The nonwoven fabric N1 or N2 of the above item 1. was randomly immersed in a rounded State in water placed into a vessel. Thereby, mosquitoes laid eggs on the nonwoven fabric as a wall surface close to the surface of the water. Therefore, the eggs were contacted with the composite particles in the nonwoven fabric to control the hatch of the eggs.
(3) Foam Polystyrène Sheet or Foam Polystyrène Beads are Floated on Water Surface
The foam polystyrène sheet or foam polystyrène beads of the above item 2. were floated on the surface of water placed into a vessel. Among mosquitoes, anopheles bearing malaria were known to lay eggs so as to be upright on the surface of the water. Therefore, the eggs of the mosquitoes were contacted with the foam polystyrène sheet and foam polystyrène beads floating on the surface of the water, whereby the hatch of the eggs were efficiently controlled.
Industrial Applicability
The présent invention can control harmful insects. In particular, the hatch of eggs of mosquitoes can be controlled. Wrigglers, which are larvae of the mosquitoes, can be killed.
Therefore, the spread of a mosquito-bome infection can be effectively prevented.
Claims (4)
- [Claim 1]A harmful insect control method comprising:contacting a composite particle including a titanium oxide particle, a métal particle,5 and a calcium phosphate particle with a harmful insect or an egg thereof in water; or placing the composite particle in the vicinity of the harmful insect or the egg in water.
- [Claim 2]The method according to claim 1, wherein the harmful insect is a harmful insect10 bearing a zoonosis.
- [Claim 3]The method according to claim 1 or 2, wherein the harmful insect bearing a zoonosis is a mosquito.
- [Claim 4]15 A harmful insect control member having:a composite particle comprising a titanium oxide particle, a métal particle, and a calcium phosphate particle on the member surface, wherein the member is used in combination with water or in water.- 46 [Claim 5]The member according to claim 4, wherein the member is any one selected from a nonwoven fabric, a vessel, a manhole, a Street inlet, and a concrète product.[Claim 6]5 A harmful insect control coating material comprising:a composite particle comprising a titanium oxide particle, a métal particle, and a calcium phosphate particle, wherein the harmful insect control coating material is used in combination with water or in water.10 [Claim 7]A harmful insect control agent comprising:a composite particle comprising a titanium oxide particle, a métal particle, and a calcium phosphate particle, wherein the harmful insect control agent is used in combination with water or in15 water.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018-100516 | 2018-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA20421A true OA20421A (en) | 2022-08-08 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2269362T3 (en) | BIOSTATIC FILTER | |
| US20080254080A1 (en) | Novel Uses of Calcium Hydroxide | |
| US20130219771A1 (en) | Bed Bug Monitoring Device | |
| US20090218266A1 (en) | Water treatment and methods of use | |
| EP3121238B1 (en) | Allergen-reducing composition, spray agent and surface treating agent containing said composition and allergen-reducing method with said composition | |
| JP2011167226A (en) | Antibacterial mask, antibacterial filter for the mask, and antibacterial method using the mask or the filter | |
| JP4342120B2 (en) | Anti-allergen composition and method for inactivating allergen | |
| KR20080005510A (en) | Allergen inactivator | |
| ES2548858T3 (en) | Parasiticidal aqueous suspension | |
| US20210368802A1 (en) | Method for controlling harmful insects | |
| OA20421A (en) | Method for controlling harmful insects. | |
| RU2540478C1 (en) | Composition for preparing antimicrobial coating | |
| KR20120112968A (en) | Method for preparing polyurethane film comprising apatite with high antibacterial function | |
| JP2010116450A (en) | Antiallergenic composition | |
| CN1852658A (en) | Aqueous parasiticidal suspension | |
| ZA200704110B (en) | Novel uses of calcium hydroxide | |
| JP2002065879A (en) | Mask | |
| JP7255931B2 (en) | Allergen-reducing composition | |
| JP3539675B2 (en) | Underfloor humidifier | |
| ES2847154T3 (en) | Coating composition with antisalt and antimicrobial activity, and procedure for its preparation | |
| JP5927625B2 (en) | Anti-allergen composition | |
| JP2020145954A (en) | Method for promoting growth of algae | |
| JP6452296B2 (en) | Allergen-reducing composition | |
| ES2821420A1 (en) | System for encapsulation and controlled release of pyrethroids with long-term efficacy against fruit flies (Machine-translation by Google Translate, not legally binding) | |
| JPH07289412A (en) | Verminfuge mat |